Issue 17 of La Revue des Microbiotes addresses the clinical aspects of these diseases, including those used to differentiate them from irritable bowel syndrome, knowledge about the dysbiotic states of the gut microbiota and the expectations for medical applications like the development of new diagnostic tests and adjuvant nutritional ecological therapies.
While there is still a long way to go, there is no doubt that part of the solutions will involve the gut microbiota.
More information on La Revue des Microbiotes website: www.larevuedesmicrobiotes.com